Lilly gets FDA EUA for bebtelovimab in mild-to-moderate Covid-19

Eli Lilly and Company (Lilly) has secured Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for bebtelovimab for the treatment of ... Read More